02/20/2025
6:31 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2025
7:48 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
7:50 PM | BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
7:51 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:31 PM | BridgeBio Pharma (Subject)
STEPHENSON BRIAN C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
3:31 PM | BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
4:23 PM | BridgeBio Pharma (Subject)
Kumar Neil (Filed by)
| Form SCHEDULE 13G/A | |
01/31/2025
6:18 PM | BridgeBio Pharma (Issuer)
HALVORSEN OLE ANDREAS (Reporting)
Ott David C. (Reporting)
Shabet Rose Sharon (Reporting)
VIKING GLOBAL INVESTORS LP (Reporting)
Viking Global Opportunities GP LLC (Reporting)
Viking Global Opportunities Illiquid Investments Sub-Master LP (Reporting)
Viking Global Opportunities Parent GP LLC (Reporting)
Viking Global Opportunities Portfolio GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
6:18 PM | BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
6:18 PM | BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SCHEDULE 13D/A | |
01/30/2025
5:29 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for BBIO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BridgeBio Pharma and its competitors with MarketBeat's FREE daily newsletter. |
01/30/2025
5:31 PM | BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
3:18 PM | BridgeBio Pharma (Subject)
STEPHENSON BRIAN C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/28/2025
3:18 PM | BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
3:53 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
4:43 PM | BridgeBio Pharma (Issuer)
MCCORMICK FRANK (Reporting)
| Form 4/A | |
12/31/2024
4:52 PM | BridgeBio Pharma (Issuer)
Satvat Ali J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
6:18 PM | BridgeBio Pharma (Issuer)
MCCORMICK FRANK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
6:05 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
6:00 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
6:00 PM | BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
6:00 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
8:16 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
6:57 PM | BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
7:00 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
5:06 PM | BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
5:13 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
5:15 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
3:24 PM | BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/12/2024
10:44 AM | BlackRock, Inc. (Filed by)
BridgeBio Pharma (Subject)
| Form SC 13G/A | |
11/06/2024
4:04 PM | BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13D/A | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
BridgeBio Pharma (Subject)
| Form SC 13G/A | |
09/17/2024
5:44 PM | BridgeBio Pharma (Issuer)
KKR & Co. Inc. (Reporting)
KKR Genetic Disorder GP LLC (Reporting)
KKR Genetic Disorder L.P. (Reporting)
KKR Group Co. Inc. (Reporting)
KKR Group Holdings Corp. (Reporting)
KKR Group Partnership L.P. (Reporting)
KKR Management LLP (Reporting)
KRAVIS HENRY R (Reporting)
ROBERTS GEORGE R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
5:41 PM | BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Filed by)
| Form SC 13D/A | |
09/13/2024
4:04 PM | BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
7:16 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
7:42 PM | BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13D/A | |
08/20/2024
5:24 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
5:27 PM | BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
5:31 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
3:27 PM | BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Important: case study on TGT (Ad) Please take a look at THIS case study on Target (TGT)
You’ll see exactly how the tool works to trade long and short, even when the markets seem to be predicting the exact opposite.
Now, this tool has been so accurate over recent months that I’m planning to send you 14 more real-world examples of winning trades that anyone using this tool could have captured.
And it’s all building to Monday, February 24 @ 1pm ET when I’ll bring the tool to the public for the first time and show you how you can put it on your own charts! Tap here to catch the TGT case study and learn more |
08/19/2024
3:29 PM | BridgeBio Pharma (Subject)
STEPHENSON BRIAN C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2024
3:39 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
4:06 PM | BridgeBio Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/01/2024
6:31 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2024
7:16 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/23/2024
3:12 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
4:38 PM | BridgeBio Pharma (Issuer)
HOMCY CHARLES J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:38 PM | BridgeBio Pharma (Issuer)
Lo Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:39 PM | BridgeBio Pharma (Issuer)
MCCORMICK FRANK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:39 PM | BridgeBio Pharma (Issuer)
Ellis Andrea (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:39 PM | BridgeBio Pharma (Issuer)
Hassan Fred (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:39 PM | BridgeBio Pharma (Issuer)
MOMTAZEE JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:40 PM | BridgeBio Pharma (Issuer)
Satvat Ali J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:42 PM | BridgeBio Pharma (Issuer)
Scott Randal W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:42 PM | BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:34 PM | AGUIAR ERIC (Reporting)
BridgeBio Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:35 PM | BridgeBio Pharma (Issuer)
Cook Jennifer E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:36 PM | BridgeBio Pharma (Issuer)
Dachille Douglas A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:36 PM | BridgeBio Pharma (Issuer)
DANIELS RONALD J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
5:01 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
3:53 PM | BridgeBio Pharma (Issuer)
Scott Randal W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
6:31 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
4:13 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
4:15 PM | BridgeBio Pharma (Filer)
| Form 424B5 | |
03/04/2024
6:00 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
6:31 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free BBIO Stock Alerts